Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN0J7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,217
Award facts
- Contract value 100% obligated
- $16,216.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,216.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectables on January 16, 2026, with completion expected by January 20, 2026. The award, which utilized no set-aside designation, represents a competitively awarded purchase of this diabetes medication to support federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc. providing organizational oversight. This delivery order is executed under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to military healthcare systems.
The DLA Medical Supply Chain utilizes this indefinite delivery contract as a critical procurement mechanism for supporting Defense Health Agency operations, the U.S. Coast Guard, and other federal healthcare systems with essential pharmaceutical commodities across multiple therapeutic domains. AmerisourceBergen's federal contract portfolio demonstrates substantial capability in fulfilling specialized pharmaceutical requirements, with transaction values ranging from under $100 to orders exceeding $45,000. The firm fixed-price delivery order structure and competitive award status reflect the company's established performance record in meeting federal medical procurement standards and timely supply chain delivery requirements for military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FN0J7?
SPE2DR26FN0J7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FN0J7 worth?
The government has obligated $16,217 on SPE2DR26FN0J7.
Is contract SPE2DR26FN0J7 an order under another contract?
Yes. SPE2DR26FN0J7 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN0J7 competed?
The extent of competition for SPE2DR26FN0J7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award